‌

US Patent 8536122 Acylated GLP-1 compounds

Patent 8536122 was granted and assigned to Novo Nordisk on September, 2013 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

Novo Nordisk

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

85361220

Date of Patent

September 17, 2013

Patent Application Number

134122830

Date Filed

March 5, 2012

Patent Citations Received

‌

US Patent 11759503 Compositions of GLP-1 peptides and preparation thereof

‌

US Patent 11833248 Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid

‌

US Patent 11759501 Compositions of GLP-1 peptides and preparation thereof

‌

US Patent 11759502 Compositions of GLP-1 peptides and preparation thereof

Patent Primary Examiner

‌

Marcela M Cordero Garcia

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8536122 Acylated GLP-1 compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API